[CAS NO. 7421-40-1]  Carbenoxolone disodium

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [7421-40-1]

Catalog
HY-B1367
Brand
MCE
CAS
7421-40-1

DESCRIPTION [7421-40-1]

Overview

MDL-
Molecular Weight614.72
Molecular FormulaC34H48Na2O7
SMILESCC(C)([C@]1([H])CC[C@@]([C@@]2(CC[C@]3(CC[C@](C[C@@]3([H])C2=C4)(C)C(O[Na])=O)C)C)5C)[C@@H](OC(CCC(O[Na])=O)=O)CC[C@]1(C)[C@@]5([H])C4=O

For research use only. We do not sell to patients.

Summary

Carbenoxolone disodium is the active metabolite of Glycyrrhizic acid (HY-N0184) and the inhibitor of human 11β-HSD and bacterial 3α, 20β-HSD [1] . Carbenoxolone disodium is an uncoupling agent for gap junctions and a potent inhibitor of Vaccinia virus replication [2] . Carbenoxolone disodium is used for the study of peptic, esophageal and oral ulceration and inflammation. Carbenoxolone disodium inhibits Vaccinia virus replication.


IC50 & Target

IC50: human 11β-HSD; bacterial 3α, 20β-HSD [1] ; gap junction; Vaccinia virus [2]


In Vitro

Carbenoxolone disodium (6-150 μM; pre-treatment 1 hour) inhibits Vaccinia virus (VACV) replication in a gap junction-independent in HaCaT cells, and it has toxicity effects on VACV-A5L-EGFP infected cells at 48 h [2] .
Carbenoxolone (30 μM; pre-treatment 1 hour) does not upregulate PP2A expression, but induces the late protein A27 expression in hacat cells [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [2]

Cell Line: HaCaT cells
Concentration: 6 μM, 12 μM, 30 μM, 60 μM, 150 μM
Incubation Time: Pre-treatment 1 hour
Result: Had no toxicity until 48 hours at high dose in virus-infected cells.

Western Blot Analysis [2]

Cell Line: HaCaT cells
Concentration: 30 μM
Incubation Time: Pre-treatment 1 hour
Result: Presented an obvious upregulation of A27.

In Vivo

Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Diazepam) does not induce a muscle relaxant activity and shows muscle relaxant activity compared to normal saline, and this effect was more than diazepam in the traction test [3] .
Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Pentylenetetrazole) significantly increases sleeping time and decreases latency in mice as a dose-dependent manner in Pentylenetetrazole (PTZ) Seizure model. The ED 50 value is 83.3 mg/kg (%95 CL:556.29) [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c mice [3]
Dosage: 100, 200 and 300 mg/kg
Administration: Intraperitoneal injection; 30, 60 and 60 min before Pentylenetetrazole
Result: Significantly increased the sleeping time in mice.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

-20°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

H 2 O : 50 mg/mL ( 81.34 mM ; Need ultrasonic)

DMSO : 16.67 mg/mL ( 27.12 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.6268 mL 8.1338 mL 16.2676 mL
5 mM 0.3254 mL 1.6268 mL 3.2535 mL
10 mM 0.1627 mL 0.8134 mL 1.6268 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 6.25 mg/mL (10.17 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 1.67 mg/mL (2.72 mM); Clear solution; Need ultrasonic

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 1.67 mg/mL (2.72 mM); Clear solution

  • 4.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 0.93 mg/mL (1.51 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, sodium salt (1:2), (3β,20β)-
Olean-12-en-30-oic acid, 3β-hydroxy-11-oxo-, hydrogen succinate, disodium salt
Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, disodium salt, (3β,20β)-
Carbenoxolone sodium
Sodium carbenoxolone
Glycyrrhetinic acid hydrogen succinate disodium salt
Carbenoxolone sodium salt
Glycyrrhetinic acid succinate disodium salt
Carbenoxolone disodium
Glycyrrhetic acid hydrosuccinate disodium salt
Disodium glycyrrhetic acid hemisuccinate
Disodium glycyrrhetinyl succinate
Carbenoxolone disodium salt
3-(Succinyloxy)glycyrrhetic acid disodium salt
Carbenoxalone disodium salt
Ulcus-Tablinen
Neogel
Pyrogastrone
Duogastrone
Sanodin
Carbenoxalone sodium
Bioral